November 3, 2016
Division of Biology Seminar Nov. 4
Submitted by Division of Biology
Jennifer Cameron, assistant professor of microbiology, immunology and parasitology at Louisiana State University Health Sciences Center's Stanley S. Scott Cancer Center, will present "Prescience is bliss: predicting the outcome of low-grade cervical dysplasia to improve clinical management" at 4 p.m. Nov. 4 in 221 Ackert Hall as part of the Division of Biology Seminar Series.
Low-grade dysplasia of the uterine cervix is commonly diagnosed among women undergoing cytologic Pap smear screenings. Two out of every three women with low-grade dysplasia will experience natural resolution of the abnormality without medical intervention within a few years, while the remaining one in three women will progress to high-grade dysplasia and will require medical treatment. Currently, women with low-grade dysplasia are followed clinically with repeat screening tests until resolution or progression of the lesion occurs.
Cameron's research program identifies factors that predict the outcome of low-grade dysplasia at the time of initial diagnosis. Factors that promote resolution of low-grade dysplasia and restoration of cervical health have potential as treatment strategies. Molecular biomarkers that predict the outcome of low-grade cervical dysplasia have potential to be targeted in clinical screening tests to facilitate timely intervention for women who are more likely to progress to high-grade dysplasia.
Cameron will discuss three ongoing projects that are unified around the theme of predicting low-grade dysplasia outcomes with the goal of improving clinical management of this common diagnosis.
If you would like to visit with Cameron, contact Nick Wallace at nwallac@k-state.edu.